Skip to main content

Table 1 Baseline characteristics

From: Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy

 

Patients, No. (%)

All (n = 286)

Low NLR (n = 158)

High NLR (n = 128)

Age

  < 65

48 (16.8)

27 (17.1)

21 (16.4)

  ≥ 65

238 (83.2)

131 (82.9)

107 (83.6)

Gender

 Male

122 (42.7)

61 (38.6)

61 (47.7)

 Female

164 (57.3)

97 (61.4)

67 (52.3)

Race

 White

271 (94.8)

148 (93.7)

123 (96.1)

 Other

15 (5.2)

10 (6.3)

5 (3.9)

KPS

 70–100

178 (62.2)

101 (63.9)

77 (60.2)

  < 70

108 (37.8)

57 (36.1)

51 (39.8)

Histology

 Adenocarcinoma

160 (55.9)

92 (58.2)

68 (53.1)

 Squamous Cell

93 (32.5)

47 (29.7)

46 (35.9)

 NSCLC (NOS)

33 (11.5)

19 (12.0)

14 (10.9)

Site

 Left

140 (49.0)

80 (50.6)

60 (46.9)

 Right

146 (51.0)

78 (49.4)

68 (53.1)

T staging

  1

235 (82.2)

136 (86.1)

99 (77.3)

2

51 (17.8)

22 (13.9)

29 (22.7)

Fractions

 1

211 (72.8)

117 (74.1)

94 (73.4)

 3

75 (26.2)

41 (25.9)

34 (26.6)

Smoking Status

 Current

79 (27.6)

50 (31.6)

29 (22.7)

 Former

188 (65.7)

97 (61.4)

91 (71.1)

 Never

19 (6.6)

11 (7.0)

8 (6.3)

Year of radiation

 2013 or earlier

220 (76.9)

125 (79.1)

95 (74.2)

 2013 or later

66 (23.1)

33 (20.9)

33 (25.8)

  1. N number, KPS Karnofsky performance, NOS not otherwise specified